Application Note

Optimizing And Scaling Lentiviral Vector Production

Scientist Using Pipette GettyImages-1140779660

Achieving Industry-Leading Titers With The VirusExpress® Platform

The VirusExpress® platform for lentiviral (LV) vectors is a defined and de-risked approach for production that leverages almost three decades of experience in viral vector development and manufacture and fit-for-purpose products to produce industry-leading titers while meeting industry expectations for recovery yield. Here, we outline how the platform's upstream and downstream workflows have been optimized through the use of design of experiments (DoE) and supplementary studies. These optimization studies help establish the VirusExpress® LV platform as a scalable, robust, and streamlined solution for suspension-based LV vector manufacturing as it addresses the needs of cell and gene therapy innovators.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online